All terms in MESH
| Label | Id | Description |
|---|---|---|
| poly(ethylene glycol)-b-poly(epsilon-caprolactone-co-gamma-hydroxyl-epsilon-caprolactone) | C578852 | |
| tenuifolic saponin | C407311 | |
| gamma-interferon-inducible lysosomal thiol reductase protein, zebrafish | C578853 | |
| antitac(FV)-PE38 recombinant immunotoxin | C407312 | |
| Kidney Transplantation | D016030 | [The transference of a kidney from one human or animal to another.] |
| Organ Transplantation | D016377 | [Transference of an organ between individuals of the same species or between individuals of different species.] |
| Urologic Surgical Procedures | D013520 | [Surgery performed on the urinary tract or its parts in the male or female. For surgery of the male genitalia, UROLOGIC SURGICAL PROCEDURES, MALE is available.] |
| Renal Replacement Therapy | D017582 | [Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys.] |
| ARFGEF1 protein, rat | C578854 | |
| enterocin ON-157 | C407313 | |
| Liver Transplantation | D016031 | [The transference of a part of or an entire liver from one human or animal to another.] |
| Digestive System Surgical Procedures | D013505 | [Surgery performed on the digestive system or its parts.] |
| Tissue Transplantation | D016378 | [Transference of tissue within an individual, between individuals of the same species, or between individuals of different species.] |
| 5'-deoxy-5-fluoroorotidine | C578855 | |
| plnA protein, Lactobacillus plantarum | C407314 | |
| Randomized Controlled Trials as Topic | D016032 | [Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.] |
| Controlled Clinical Trials as Topic | D018849 | [Works about clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.] |
| 1-(beta-D-erythrofuranosyl)-5-fluoroorotic acid | C578856 | |
| 3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo-(2-3b)-indole-2-carboxylic acid | C407304 | |
| Case-Control Studies | D016022 | [Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time.] |